What is Darier sign and how is it used in the diagnosis and management of mastocytosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Darier Sign

Darier sign is a clinical diagnostic finding characterized by urtication (wheal formation) and erythema (flare) that develops within minutes when a mastocytosis skin lesion is rubbed or stroked, resulting from the release of histamine, leukotrienes, and prostaglandins from degranulating mast cells. 1

Clinical Significance in Diagnosis

Darier sign serves as a pathognomonic clinical marker for cutaneous mastocytosis, though it is not universally present in all patients. 1 The sign is elicited by mechanical irritation of the lesion and typically appears positive in 89-94% of pediatric mastocytosis cases. 1 In adults, the sign remains a key diagnostic feature when evaluating suspected cutaneous lesions of mastocytosis. 2

Diagnostic Approach

When evaluating a patient with suspected mastocytosis:

  • Physical examination should specifically test for Darier sign by gently stroking or rubbing a suspected lesion and observing for urtication within 2-5 minutes 1
  • A positive Darier sign, combined with typical lesion morphology (erythematous to violaceous macules/papules, brown-yellow nodules, or diffusely thickened skin), strongly suggests cutaneous mastocytosis 1, 2
  • The diagnosis of cutaneous mastocytosis in children can often be made clinically based on: manifestation in infancy, typical morphology and distribution, and pathognomonic Darier sign 3

Important Caveats

Darier sign is not 100% sensitive - its absence does not exclude mastocytosis. 1 When the clinical presentation is suggestive but Darier sign is negative or equivocal, proceed with:

  • Skin biopsy with hematoxylin & eosin, Giemsa staining, and immunostaining for tryptase and KIT 1
  • D816V KIT mutational analysis in tissue to confirm clonal mast cell proliferation 4
  • Serum tryptase measurement (baseline) 1, 3

Role in Management Decisions

The presence of Darier sign helps stratify disease severity and guide further workup:

  • Positive Darier sign with typical lesions in children: Usually requires only symptomatic management with antihistamines and trigger avoidance 3, 5
  • Positive Darier sign with extensive lesions or systemic symptoms: Warrants serum tryptase measurement and consideration of bone marrow evaluation if tryptase >20 ng/mL, severe systemic symptoms present, organomegaly detected, or inadequate response to initial therapy 1

Correlation with Disease Activity

The intensity of Darier sign correlates with disease activity and mast cell burden. 1 Patients with more pronounced urtication upon stroking tend to have:

  • Higher serum tryptase levels
  • Greater extent of skin involvement
  • More frequent associated symptoms (pruritus, flushing, diarrhea) 1

Practical Application

In solitary cutaneous mastocytoma, the diagnosis is primarily clinical based on lesion morphology, positive Darier sign, and absence of systemic involvement - skin biopsy is unnecessary unless diagnosis is uncertain. 6

In less typical presentations (telangiectatic variants, confluent or nodular forms), a clearly positive Darier sign becomes more critical for diagnosis, though histopathological confirmation may still be required. 7, 4

The sign remains useful throughout follow-up to monitor disease activity, though its presence alone does not predict progression to systemic disease. 1

References

Research

Mastocytosis: Part I: Pathogenesis, Clinical Presentation and Classification.

Journal of the American Academy of Dermatology, 2025

Research

Cutaneous mastocytosis in childhood.

Allergologie select, 2022

Research

Challenges in the Diagnosis of Cutaneous Mastocytosis.

Diagnostics (Basel, Switzerland), 2024

Research

[Pediatric cutaneous mastocytosis].

Revue medicale de Liege, 2020

Research

Challenges in Cutaneous Mastocytosis.

Immunology and allergy clinics of North America, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.